>
Skip left side navigation and go to content

The Diagnosis, Evaluation and Management of von Willebrand Disease

Financial and Other Disclosures

The participants who disclosed potential conflicts are:

  • Dr. Andra H. James (medical advisory panel for ZLB Behring and Bayer; NHF, MASAC),

  • Dr. Marilyn Manco-Johnson (ZLB Behring Humate PÆ Study Steering Committee and Grant Recipient, Wyeth Speaker, Bayer Advisor and Research Grant Recipient, Baxter Advisory Committee and Protein C Study Group, Novo Nordisk Advisory Committee),

  • Dr. Robert Montgomery (Aventis Foundation Grant; GTI, Inc., VWFpp Assay; ZLB Behring and Bayer Advisory Group; NHF, MASAC), and

  • Dr. William Nichols (Mayo Special Coagulation Laboratory serves as "central lab" for Humate-PÆ study by ZLB Behring).

All members submitted financial disclosure forms.


Skip footer links and go to content
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon